[Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings]

MeSH terms

• Adalimumab
• Aged
• Antibodies, Monoclonal, Humanized / economics*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Antirheumatic Agents / economics*
• Antirheumatic Agents / therapeutic use*
• Disease Progression
• Drug Costs / legislation & jurisprudence
• Drug Therapy, Combination
• Evidence-Based Medicine / legislation & jurisprudence
• Expert Testimony / legislation & jurisprudence
• Female
• Humans
• Insurance Coverage / economics*
• Insurance Coverage / legislation & jurisprudence*
• Insurance, Pharmaceutical Services / economics
• Insurance, Pharmaceutical Services / legislation & jurisprudence
• Isoxazoles / adverse effects
• Isoxazoles / economics*
• Isoxazoles / therapeutic use*
• Leflunomide
• Methotrexate / adverse effects
• Methotrexate / therapeutic use
• National Health Programs / economics*
• National Health Programs / legislation & jurisprudence*
• Off-Label Use / economics*
• Off-Label Use / legislation & jurisprudence*
• Prednisolone / economics
• Prednisolone / therapeutic use
• Tumor Necrosis Factor Inhibitors*